Answers are grounded in this paper and cite their sources.
Observational analysis shows diagnostic accuracy of RT-PCR assays for Delta and Omicron variants, indicating reliability in testing.
New severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants may affect diagnostic test accuracy. To evaluate the performance of two reverse transcription-polymerase chain reaction (RT-PCR) assays, DaAn Gene and Cepheid, for detecting Delta and Omicron variants. Nasopharyngeal samples were collected in Yaoundé, Cameroon, between October 2021 and December 2022. Nasopharyngeal samples were tested with both assays. Samples with a cycle threshold (CT) ≤ 28 were sequenced. Cohen's kappa coefficient assessed assay agreement. We compared 294 samples. At CT ≤ 40, DaAn Gene showed a 59.2% (n = 174/294) positivity rate versus 57.8% (n = 170/294) for Cepheid (χ2 = 0.695, p = 0.4044). Agreement was 95.91% (n = 282/294) with κ = 0.95. DaAn Gene showed a 58.2% (n = 171/294) positivity rate versus 54.4% (n = 160/294) for Cepheid at CT ≤ 37 (p = 0.5058), with 95.6% agreement (κ = 0.95). At CT ≤ 33, DaAn Gene was 56.5% (n = 166/294) positive versus 54.1% (n = 159/294) for Cepheid (p = 0.6187), with 96.93% agreement (κ = 0.938). For 167 samples with CT ≤ 28, agreement was 97.0% (κ = 0.97) across variants. These RT-PCR assays effectively detected Delta and Omicron variants. The emergence of Delta and Omicron variants did not significantly impact the diagnostic performance of these routine RT-PCR assays. This study confirms their continued effectiveness in detecting these variants in this setting.
No takes yet. Share an insight, caveat, or question.
Maïdadi‐Foudi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: